6CPO | Immune System | date | Mar 13, 2018 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Dr15 Presenting The Rq13 Peptide | ||||||||||||||
authors | C.Farenc, S.Gras, J.Rossjohn | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Hla Class II Histocompatibility Antigen, Dr Alpha Chain: A, D Synonym: Mhc Class II Antigen Dra Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Hla-Dra, Hla-Dra1 Expression_system: Homo Sapiens Expression_system_taxid: 9606 | ||||||||||||||
Molecule: Hla-Drb1 Protein Chain: B, E Synonym: Mhc Class II Antigen Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Hla-Drb1 Expression_system: Homo Sapiens Expression_system_taxid: 9606 | ||||||||||||||
Molecule: Rq13 Chain: C, F Synonym: Pr55gag Engineered: Yes |
Synthetic: Yes Organism_scientific: Hiv-1 M:B_hxb2r Organism_taxid: 11706 | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.40 Å | ||||||||||||
ligand | NAG, PGE, PO4 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | CD4(+) T cell-mediated HLA class II cross-restriction in HIV controllers., Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, Tan LL, Ciacchi L, Reid HH, Rossjohn J, Chakrabarti LA, Gras S, Sci Immunol. 2018 Jun 8;3(24). pii: 3/24/eaat0687. doi:, 10.1126/sciimmunol.aat0687. PMID:29884618 |
Data retrieval |
View 6CPO in 3D |
Visual 3D analysis of 6CPO |
Structure-derived information |
Sequence-derived information |
Other resources with information on 6CPO |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |